Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Schizophrenia

Free Subscription 30.05.2022 1 Biol Psychiatry 1 Br J Psychiatry 1 Mol Psychiatry 1 Neurosci Lett 1 PLoS One 2 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biol Psychiatry

1. ENDRES D, von Zedtwitz K, Matteit I, Bunger I, et al
   Spectrum of Novel Anti-Central Nervous System Autoantibodies in the Cerebrospinal Fluid of 119 Patients With Schizophreniform and Affective Disorders.
   Biol Psychiatry. 2022 Feb 19. pii: S0006-3223(22)00097.
   PubMed         Abstract available
   
   

   
   Br J Psychiatry

2. CURTIS D
   Identification of specific genes involved in schizophrenia aetiology - what difference does it make? - CORRIGENDUM.
   Br J Psychiatry. 2022 May 23:1. doi: 10.1192/bjp.2022.
   PubMed        
   
   

   
   Mol Psychiatry

3. PERZEL MANDELL KA, Eagles NJ, Deep-Soboslay A, Tao R, et al
   Molecular phenotypes associated with antipsychotic drugs in the human caudate nucleus.
   Mol Psychiatry. 2022;27:2061-2067.
   PubMed         Abstract available
   
   

   
   Neurosci Lett

4. REN J, Chen Y, Fang X, Wang D, et al
   Correlation of Orexin-A and brain-derived neurotrophic factor levels in metabolic syndrome and cognitive impairment in schizophrenia treated with clozapine.
   Neurosci Lett. 2022 May 23:136695. doi: 10.1016/j.neulet.2022.136695.
   PubMed         Abstract available
   
   

   
   PLoS One

5. ALGUMAEI AH, Algunaid RF, Rushdi MA, Yassine IA, et al
   Feature and decision-level fusion for schizophrenia detection based on resting-state fMRI data.
   PLoS One. 2022;17:e0265300.
   PubMed         Abstract available
   
   

   
   Schizophr Res

6. WILLIAMS TF, Powers AR, Ellman LM, Corlett PR, et al
   Three prominent self-report risk measures show unique and overlapping utility in characterizing those at clinical high-risk for psychosis.
   Schizophr Res. 2022;244:58-65.
   PubMed         Abstract available
   
   
7. SCHIFFMAN J, Horton LE, Landa Y, Woods SW, et al
   Considerations for providing feedback to patients and families regarding clinical high-risk for psychosis status.
   Schizophr Res. 2022;244:55-57.
   PubMed        
   
   

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: